GLOBUS MEDICAL

NYSE: GMED (Globus Medical, Inc.)

Last update: 26 Dec, 2024, 12:47PM

83.94

0.47 (0.56%)

Previous Close 83.47
Open 83.07
Volume 117,705
Avg. Volume (3M) 906,377
Market Cap 11,429,859,328
Price / Earnings (TTM) 135.39
Price / Earnings (Forward) 25.25
Price / Sales 4.78
Price / Book 2.91
52 Weeks Range
49.33 (-41%) — 87.22 (3%)
Earnings Date 18 Feb 2025 - 24 Feb 2025
Profit Margin 3.69%
Operating Margin (TTM) 17.67%
Diluted EPS (TTM) 0.620
Quarterly Revenue Growth (YOY) 63.10%
Quarterly Earnings Growth (YOY) 5,094.00%
Total Debt/Equity (MRQ) 13.18%
Current Ratio (MRQ) 2.51
Operating Cash Flow (TTM) 414.97 M
Levered Free Cash Flow (TTM) 473.36 M
Return on Assets (TTM) 4.73%
Return on Equity (TTM) 2.22%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Globus Medical, Inc. Bullish Bullish

AIStockmoo Score

1.8
Analyst Consensus 4.0
Insider Activity NA
Price Volatility -0.5
Technical Moving Averages 1.5
Technical Oscillators 2.0
Average 1.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GMED 11 B - 135.39 2.91
BSX 143 B - 79.93 6.75
SYK 139 B 0.89% 39.08 6.83
PHG 23 B - - 1.86
ABT 204 B 1.93% 35.47 5.04
MDT 102 B 3.49% 24.43 2.25

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Sector Healthcare
Industry Medical Devices
Investment Style Mid Growth
% Held by Insiders 0.62%
% Held by Institutions 82.10%
52 Weeks Range
49.33 (-41%) — 87.22 (3%)
Price Target Range
90.00 (7%) — 115.00 (37%)
High 115.00 (Roth MKM, 37.00%) Buy
Median 96.00 (14.37%)
Low 90.00 (Truist Securities, 7.22%) Hold
Average 97.30 (15.92%)
Total 8 Buy, 2 Hold
Avg. Price @ Call 83.65
Firm Date Target Price Call Price @ Call
Canaccord Genuity 10 Jan 2025 101.00 (20.32%) Buy 87.07
09 Dec 2024 92.00 (9.60%) Buy 82.92
B of A Securities 09 Jan 2025 97.00 (15.56%) Hold 86.55
06 Nov 2024 80.00 (-4.69%) Sell 82.71
Truist Securities 18 Dec 2024 90.00 (7.22%) Hold 81.78
Roth MKM 17 Dec 2024 115.00 (37.00%) Buy 83.42
06 Nov 2024 100.00 (19.13%) Buy 82.71
BTIG 12 Dec 2024 91.00 (8.41%) Buy 82.71
Wells Fargo 11 Dec 2024 95.00 (13.18%) Buy 82.94
06 Nov 2024 88.00 (4.84%) Buy 82.71
Morgan Stanley 02 Dec 2024 100.00 (19.13%) Buy 83.90
11 Nov 2024 83.00 (-1.12%) Hold 81.99
Piper Sandler 06 Nov 2024 100.00 (19.13%) Buy 82.71
RBC Capital 06 Nov 2024 92.00 (9.60%) Buy 82.71
Stifel 06 Nov 2024 92.00 (9.60%) Buy 82.71
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria